TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients

Telomerase reverse transcriptase gene promoter (TERTp) mutations are recognized as one of the most frequent genetic events in bladder cancer (BC). No studies have focused on the relevance of TERTp mutations in the specific group of tumors treated with Bacillus Calmette–Guérin (BCG) intravesical ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Batista, Rui, Lima, Luís, Vinagre, João, Pinto, Vasco, Lyra, Joana, Máximo, Valdemar, Santos, Lúcio, Soares, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037401/
https://www.ncbi.nlm.nih.gov/pubmed/32023888
http://dx.doi.org/10.3390/ijms21030947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037401/
https://www.ncbi.nlm.nih.gov/pubmed/32023888
http://dx.doi.org/10.3390/ijms21030947

Ejemplares similares